← Back to blog

Digital Health Advisor: What One Does and When You Need One

November 21, 2026
Digital Health Advisor: What One Does and When You Need One

A digital health advisor is an experienced operator who helps a healthcare technology company make better clinical, regulatory and commercial decisions than its team could make alone. The most useful ones combine real patient-care experience with startup and investor experience. For a healthcare SaaS company, that often means a physician executive, such as a Fractional Chief Medical Officer, who works inside the business on a defined scope instead of sitting on a name list.

This guide is for founders, healthtech executives, and the investors who back them. It covers what an advisor does, how the role differs from a consultant or a board seat, the moments when one pays off, and how to structure the relationship so it produces results.

The StartupMD
Bring Healthcare and Startup Insight Together
The StartUp MD offers tailored advisory and fractional consulting for healthcare SaaS startups navigating growth challenges, from product-market fit to fundraising.
Visit

TL;DR

  • A digital health advisor brings clinical, regulatory and go-to-market judgment that a young healthcare SaaS team usually lacks in-house.
  • An advisor gives ongoing guidance, a consultant answers a defined question, and a board member holds formal governance duties. Pick the one that matches the problem.
  • The strongest triggers are product-market fit doubts, stalled clinician adoption, regulatory uncertainty, and an upcoming raise or diligence process.
  • Put scope, time commitment, confidentiality, conflicts and review points in writing, and measure the work against milestones.
  • For hands-on medical leadership without a full-time executive hire, a Fractional CMO is the most direct form of advisor.

Table of Contents

What a digital health advisor actually does

The title is loose. In practice, a digital health advisor is a person with deep experience in healthcare delivery, health technology, or both, who gives a company judgment it cannot buy from a generalist.

Before going further, it helps to define the field. PitchBook describes healthtech as any application of technology in healthcare products and services, with a digital health vertical that covers virtual care delivery, telemedicine, digital therapeutics and chronic condition management. The U.S. International Trade Administration describes health IT, also called digital health or connected health, as the use of hardware and software to store, retrieve, share and use healthcare information. That is a wide field. It spans a remote monitoring app, a clinical workflow platform, an AI documentation tool and a payer analytics product. A good advisor knows which of those problems belong to the clinic, which belong to the regulator, and which belong to the buyer.

The work usually falls into five areas.

Clinical credibility and product design

A healthcare product has to be clinically sound and fit how care is actually delivered. An advisor with clinical experience tests the product against real workflows: who touches the data, when, and what they stop doing to make room for your tool. Clinical strategy is where this starts, and our guide to clinical strategy for digital health companies covers it in depth.

Regulatory and privacy orientation

In the United States, digital health sits under several authorities. According to the ICLG 2026 USA digital health report, HHS oversees digital health through agencies including FDA, CMS, OIG and OCR. The FTC regulates through its Health Breach Notification Rule, which applies to most health apps not covered by HIPAA. A founder who assumes one rule set covers the product can be wrong in expensive ways.

The rules are also moving. A law firm summary of FDA's 2026 updates describes revised guidance on clinical decision support software and general wellness products that changes how some software is treated. An advisor does not replace regulatory counsel. The advisor's job is to help you ask counsel the right questions early, before the product design is locked.

Clinician and buyer adoption

Health systems and provider groups do not buy software because it is clever. They buy it when clinicians trust it and operations can absorb it. An advisor who has practiced medicine can tell you why a physician champion will not sign on, or why a pilot stalled after the first month.

Go-to-market and positioning

The same person can help you reframe the message from features to outcomes a medical director, CFO or quality lead cares about. This is where physician engagement and commercial strategy meet.

Investor and board readiness

Investors ask clinical questions in diligence: evidence, safety, workflow risk, regulatory path. An advisor helps you answer them with a credible story, and helps investors evaluate a portfolio company's clinical risk with an informed outside view.

Advisor, consultant, board member or Fractional CMO

Founders often use these words interchangeably. They are different arrangements, and choosing the wrong one is a common reason an engagement disappoints.

RoleTypical scopeTime horizonAuthority
ConsultantA specific question or project, such as a market readiness assessmentLimited, often per project or hourlyRecommends, does not govern
AdvisorOngoing guidance based on a particular skill setOngoing, informal cadenceNo vote, no executive role
Board memberGovernance and oversightFormal termVoting rights, fiduciary duties
Fractional executiveOwns a function part-time, such as medical leadershipRetainer, defined hoursOperates as part of the leadership team

The distinction between consultants and advisors comes from physician advisor Nisha Mehta, who explains that consultants are brought in on a limited basis to answer a specific question, while advisor roles are ongoing and chosen for a particular skill set. She also notes that advisory-board positions generally lack voting rights, unlike board-of-director seats, which carry more legal complexity and potential liability.

That last point matters to founders. An advisory board member gives opinions. They do not own outcomes. If your problem is that nobody inside the company owns clinical decisions, a name on an advisory list will not fix it. You need someone with accountability for the function.

This is why many healthcare SaaS companies move from informal advisors to a Fractional Chief Medical Officer. The CMO role is executive medical leadership: setting clinical direction, working with product and engineering, representing the company with clinicians and customers, and supporting investor conversations. The fractional model gives a company that leadership at a part-time scale, without a full-time executive salary before the company needs one. We explore the governance side in Turn Advisory Board Theater Into Adoption, which is aimed at founders whose advisory boards look impressive but do not change what happens in the product.

When a healthtech company needs an advisor

Not every company needs one at every stage. These are the moments when the case is strongest.

You are not sure you have product-market fit

Users sign up, but clinicians do not change behavior. Pilots do not convert to contracts. Sales cycles drag because buyers cannot see the clinical or financial case. In these situations the problem is often not the code. It is a mismatch between what the product assumes about care delivery and what really happens on a Tuesday afternoon in a clinic. An advisor who has lived that reality can diagnose it faster than another round of user interviews.

Clinician adoption is stalling

If your champions leave, your product gets used by one enthusiastic doctor and no one else, or nurses and medical assistants work around the tool, you have a clinical operations problem. Our founder's guide to clinical operations for a healthtech startup lays out how to fix workflow fit.

Regulatory or privacy questions are looming

If you are adding AI features, handling patient data, or moving from wellness claims toward clinical claims, your regulatory posture changes. The shift from a general wellness product to one making diagnostic or treatment claims is exactly where a mistake gets costly. Marketing claims fall under the same scrutiny, and a primer on HIPAA marketing rules is a useful companion when your growth team starts using patient information.

A raise or diligence process is coming

Investors in healthtech expect more than a pitch deck. They look for clinical validation, a credible regulatory path, evidence that the buyer will pay, and leadership that understands care delivery. If the team has no physician leader, that gap shows up in diligence. Support before the raise is cheaper than a failed process.

You are an investor with a portfolio company in trouble

Venture and private equity firms with healthcare holdings often see the same pattern: strong engineering, solid sales, but no one able to say whether the clinical story holds up. An outside medical executive can assess the product, the market readiness and the leadership gaps, and give the portfolio company a plan the board can track.

You are scaling and the founder is the bottleneck

In many early healthtech companies, every clinical question lands on the founder. Past a certain point, that does not scale. Delegating it to a part-time medical executive buys back the founder's time for fundraising and customers.

How advisory support helps with fit, growth and fundraising

The value of an advisor shows up in three practical ways.

Validating fit. A clinical advisor can design a small number of focused tests: a workflow walkthrough with real clinicians, a pilot with clear success criteria, a review of what outcome data a buyer will accept. This replaces vague enthusiasm with evidence you can act on.

Growing without breaking the product. Growth in healthcare adds complexity: new sites, new specialties, new payer relationships. Someone has to decide what clinical content scales, what needs a physician in the loop, and what you should refuse to build.

Raising on a stronger story. Founders who can explain their clinical rationale, safety approach and regulatory path in plain terms raise with less friction. The advisor helps shape that narrative, and can sit in on investor conversations where clinical depth is expected.

None of this guarantees a result. What it does is move decisions from guesswork to informed judgment.

How advisory support helps with fit, growth and fundraising

How to structure the relationship

Most advisory arrangements fail because they are vague, not because the advisor is poor. Legal advisers at Pillsbury Propel recommend putting every advisor relationship in writing, covering the role, term and exit, time-commitment limits, confidentiality, IP ownership, conflicts of interest and compensation. Have your own counsel draft the agreement.

A workable approach looks like this:

  1. Name the problem first. "We need an advisor" is not a scope. "We need a clinical safety review of our AI triage feature before the Series A" is.
  2. Match the form to the problem. A defined question calls for a project. An ongoing need for judgment calls for an advisor. Ownership of a function calls for a fractional executive.
  3. Set the time and cadence. Agree on hours per month and how the advisor is reached, so the relationship does not depend on goodwill.
  4. Handle conflicts openly. Healthcare is a small world. If the advisor works with adjacent companies, say so and set the boundaries in writing.
  5. Build review points. Pillsbury Propel's Ellen Grady recommends review points so the relationship can evolve or end gracefully, with any equity vesting tied to goals such as product validation or regulatory approval. Quarterly reviews against the original problem are a simple version.
  6. Watch the cap table. Equity paid to advisors dilutes everyone. Keep grants proportionate to the contribution.
  7. Measure what changed. Did the pilot convert? Did diligence questions get cleaner answers? Did the product roadmap shift based on clinical input? If nothing changed, change the arrangement.

What to look for in a digital health advisor

Credentials matter less than fit with your problem. Ask these questions.

  • Have they practiced? Direct patient-care experience tells you the advisor knows how clinicians think under time pressure.
  • Have they worked with startups? Enterprise health system experience does not always transfer to a ten-person company.
  • Do they understand both sides of the deal? The best advisors read a contract with a health system and a term sheet with equal ease.
  • Will they be available? Mehta argues it is better to advise a few companies deliberately than to spread across many boards, because companies depend on the advisor's bandwidth. Ask how many engagements they carry.
  • Can they own outcomes? If you need accountability, look for someone willing to take a defined executive scope.

Where The StartUp MD fits

The StartUp MD is a healthcare advisory firm for healthcare SaaS and digital health companies. It offers two kinds of engagement: project-based advisory services and retainer-based Fractional Chief Medical Officer leadership. The work covers clinical strategy, product evaluation, regulatory guidance, clinical operations consulting, market readiness assessment, investor support, and executive and board advising.

The firm is led by Paul Bergeron, MD, MBA, who brings more than 25 years of experience in medicine and business. That combination matters to the reader of this guide: founders get direct access to an advisor with both clinical and business expertise, and investors get a single outside voice who can speak to the product, the market and the leadership team.

Perspective: why we put medical leadership at the center

I have seen the same gap in healthcare technology companies again and again. The engineering is strong. The sales effort is real. But no one at the table has practiced medicine, so clinical decisions get made by whoever speaks first.

That is the gap a Fractional Chief Medical Officer is built to close. We believe a healthtech company needs a physician voice that owns decisions, not one that offers opinions once a quarter. Real patient care experience, paired with startup and investor experience, changes the conversation about the product, the evidence and the market.

This is why our advisory work is hands-on. We work on clinical strategy, product evaluation, regulatory guidance and market readiness, and we support founders in investor conversations. Our aim is outcomes you can measure, such as a clearer path to funding, better operational efficiency and better care.

If something in your product, your adoption numbers or your board materials feels misaligned, I would welcome a conversation.

Paul Bergeron MD, MBA

Work with a physician executive who has built in this space

If the questions above sound familiar, the next step is a conversation about scope. The StartUp MD provides Fractional Chief Medical Officer and advisory services for healthcare SaaS companies, digital health startups and the investors behind them. Pricing is set per engagement, whether project-based or retainer-based.

The StartupMD

You can also see the full approach at The StartUp MD.

FAQ

What is the difference between a digital health advisor and a consultant?

A consultant is typically hired for a limited project or a specific question and paid per project or hour. An advisor provides ongoing guidance based on a particular skill set, and holds no vote and no executive role. Many healthtech companies use both at different stages.

Is a digital health advisor the same as a Fractional CMO?

Not quite. An advisor gives guidance, while a Fractional Chief Medical Officer takes on executive medical leadership for a defined number of hours. If your company needs someone to own clinical strategy, physician engagement and investor-facing clinical credibility, the fractional executive model fits better than an informal advisory seat.

When should a healthtech startup hire an advisor?

The clearest triggers are doubts about product-market fit, stalled clinician adoption, new regulatory exposure such as AI or patient data features, and an upcoming fundraise. Investors with portfolio companies facing the same issues can also bring in an advisor to assess clinical risk.

What kinds of companies count as digital health?

The category is broad. PitchBook's digital health vertical includes virtual care, telemedicine, digital therapeutics and chronic condition management, alongside health IT and medtech. Healthcare SaaS platforms that sit in clinical workflows or serve payers and providers fall squarely within it.

How should I structure an advisory agreement?

Put it in writing. Cover role, term, time commitment, confidentiality, IP ownership, conflicts of interest and compensation, and add review points tied to milestones. Have your attorney draft the final document, particularly where equity is involved.

Sources